Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances and challenges in precision medicine in salivary gland cancer
Gerben Lassche, Wim van Boxtel, Marjolijn J. L. Ligtenberg, et al.
Cancer Treatment Reviews (2019) Vol. 80, pp. 101906-101906
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up
C. van Herpen, Vincent Vander Poorten, Alena Skálová, et al.
ESMO Open (2022) Vol. 7, Iss. 6, pp. 100602-100602
Open Access | Times Cited: 111
Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment
Masato Nakaguro, Yuichiro Tada, William C. Faquin, et al.
Cancer Cytopathology (2020) Vol. 128, Iss. 10, pp. 693-703
Open Access | Times Cited: 108
The evolving landscape of salivary gland tumors
Conor Steuer, Glenn J. Hanna, Kartik Viswanathan, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 73, Iss. 6, pp. 597-619
Open Access | Times Cited: 30
Neratinib and the Role of Anti‐HER2 Therapy in Salivary Duct Carcinoma
Martina Napolitano, Lucia Trudu, E. Martinelli, et al.
Cancer Reports (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Salivary Gland Cancers in the Era of Molecular Analysis: The Role of Tissue and Liquid Biomarkers
Elisabetta Broseghini, Francesca Carosi, M. BERTI, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 660-660
Open Access | Times Cited: 1
Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review
Maike J.M. Uijen, Gerben Lassche, Adriana C. H. van Engen‐van Grunsven, et al.
Cancer Treatment Reviews (2020) Vol. 89, pp. 102069-102069
Open Access | Times Cited: 45
Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapy
James Nightingale, Benedict Lum, Rahul Ladwa, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1875, Iss. 2, pp. 188523-188523
Closed Access | Times Cited: 39
Oral Cancer Stem Cells: Therapeutic Implications and Challenges
Linah A. Shahoumi
Frontiers in Oral Health (2021) Vol. 2
Open Access | Times Cited: 36
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study
Renata Ferrarotto, Paul Swiecicki, Dan P. Zandberg, et al.
Oral Oncology (2023) Vol. 149, pp. 106634-106634
Open Access | Times Cited: 13
Potentially actionable molecular alterations in particular related to poor oncologic outcomes in salivary gland carcinomas
Julia Pikul, Marcin M. Machnicki, Anna Rzepakowska, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio predict poor prognosis in patients diagnosed with salivary gland adenoid cystic carcinoma
Zhibin Yang, Yizhen Wang, Chunyun Wang, et al.
Journal of Cranio-Maxillofacial Surgery (2025)
Closed Access
Clinical Outcomes of Intensity Modulated Proton Therapy for Salivary Gland Carcinoma: High Local Control and Quality of Life Preservation
Gaku Takano, Daisuke Kawakita, Hiromitsu Iwata, et al.
Head & Neck (2025)
Open Access
Development and characterization of patient-derived salivary gland cancer organoid cultures
Gerben Lassche, Wim van Boxtel, Tilly Aalders, et al.
Oral Oncology (2022) Vol. 135, pp. 106186-106186
Open Access | Times Cited: 17
Increased retinoic acid signaling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical Notch1 pathway
Mengjiao Zhou, Jiajie Yang, Tingyao Ma, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 597-611
Open Access | Times Cited: 10
Salivary gland tumours: update on molecular diagnostics
Karwan Moutasim, Gareth J. Thomas
Diagnostic histopathology (2020) Vol. 26, Iss. 4, pp. 159-164
Open Access | Times Cited: 26
Systemic therapies for salivary gland carcinoma (excluding adenoid cystic carcinoma): REFCOR recommendations by the formal consensus method
Victor Sarradin, Laurence Digue, S. Vergèz, et al.
European Annals of Otorhinolaryngology Head and Neck Diseases (2023) Vol. 141, Iss. 5, pp. 280-285
Closed Access | Times Cited: 8
Systemic therapies for salivary gland cancer: Adenoid cystic carcinoma. REFCOR recommendations by the formal consensus method
François‐Régis Ferrand, Caroline Even, É. Chabrillac, et al.
European Annals of Otorhinolaryngology Head and Neck Diseases (2023) Vol. 141, Iss. 5, pp. 286-291
Closed Access | Times Cited: 8
Identification of Fusion Genes and Targets for Genetically Matched Therapies in a Large Cohort of Salivary Gland Cancer Patients
Gerben Lassche, Sjoerd van Helvert, Astrid Eijkelenboom, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4156-4156
Open Access | Times Cited: 13
Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images
Lele Song, Shun-jun Chen, Wang Chen, et al.
BMC Medical Imaging (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade
Gerben Lassche, Yuichiro Tada, Carla M.L. van Herpen, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3527-3527
Open Access | Times Cited: 17
Pulmonary Salivary Gland Tumor, Mucoepidermoid Carcinoma: A Literature Review
Shumin Hu, Jiali Gong, Xiu Zhu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 12
A population-based competing risk survival analysis of patients with salivary duct carcinoma
Jianchuan Ran, Huihui Zou, Xiaoye Li, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 21, pp. 1355-1355
Open Access | Times Cited: 15
Postoperative Management of Salivary Gland Tumors
Nikhil Joshi, James R. Broughman
Current Treatment Options in Oncology (2021) Vol. 22, Iss. 3
Closed Access | Times Cited: 14
Proton Therapy for Major Salivary Gland Cancer: Clinical Outcomes
Alexander N. Hanania, Xiaodong Zhang, G. Brandon Gunn, et al.
International Journal of Particle Therapy (2021) Vol. 8, Iss. 1, pp. 261-272
Open Access | Times Cited: 13
Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review
Giuditta Mannelli, Lara Valentina Comini, Andrea Sacchetto, et al.
Head & Neck (2022) Vol. 44, Iss. 8, pp. 1961-1975
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top